Sean T. Smith
Analyst · Needham & Company, your line is now open
Thanks Peter and good morning everyone. I will provide a brief analysis of our financial results for the fourth quarter of 2014. We view our operating results, balance sheet, cash flows, and forecast. Please turn to slide 6, 7, and 8 which shows our sequential, quarterly, and year-over-year IC and FPD revenue performance. Fourth quarter revenues was approximately 123 million down 600k sequentially due to the reasons Peter mentioned. Revenues for IC photomask were $99.4 million down $1.2 million sequentially. Revenues for high end IC photomask which are 45 nanometers and below were $33.5 million or 34% of total IC sales. Sequentially high-end IC revenue decreased $3.1 million. The decrease was primarily related to reduced high-end pay downs in Taiwan and to a lesser extent the U.S. The decrease was partially offset by increased sequential IC mainstream revenue of 1.9 million. For 2014 high-end IC revenue increased 30% to $104 million while mainstream sales increased $8 million to $249 million. As a reminder our mainstream business is a significant cash generator for us. Revenues for FPD photomask were $24.9 million up $600,000 sequentially. High-end FPD revenue for the quarter at $15.2 million was essentially flat on a sequential basis. Breaking out Q4 sales geographically, 71% of total sales were from Asia, 22% from North America, and 7% from Europe. Now let's continue through the income statement. Gross margins for the fourth quarter was 21.4% down 150 basis sequentially. The decrease was related to increased manufacturing cost principally equipment, the bulk of which is not expected to be recurring. Selling, general and administrative expenses for the fourth quarter were $11.5 million. SG&A decreased approximately $800,000 sequentially as a result of cost savings and cost avoidance programs. R&D expenses which consists principally of continued development for our global advanced process technologies and qualifications at advanced nodes were $5.8 million up $600k sequentially. During the quarter we generated operating income of $9.3 million or 7.5%. EBITDA as defined in our credit agreement for the fourth quarter was $33 million down $1 million sequentially. This represents a $117 million for the year, also our free cash flow for the year was $25 million. Other expense net for the fourth quarter was down $600k sequentially principally driven by foreign exchange, favorable foreign exchange. During the fourth quarter we reported tax provision of approximately $2 million and minority interest expense was $2.4 million and principally consists of DNP share of PDMC’s profits for the fourth quarter. Minority interest expense decreased 700,000 during the quarter. GAAP and non-GAAP net income was $4.3 million or $0.07 per share. At the end of the fourth quarter we had 1500 full-time employees which equates to annualized revenue per employee of $331,000. Now turning to the balance sheet, for fiscal 2014 we have strengthened our consolidated balance sheet including our net cash position from $22 million at the beginning of 2014 to $51 million at year-end. Cash and cash equivalents at the end of the quarter amounted to $193 million. As I mentioned, our net cash which is cash plus debt was $51 million at the end of the quarter, up $22 million sequentially, principally as a result of our previous outstanding 5.5% $22 million convertible notes converted to equity in October. Our working capital at the end of the quarter was $197 million as compared to $205 million at the end of Q3. Accounts receivable at the end of the quarter decreased $8.4 million sequentially to $94.5 million primarily as a result of improved collections. AP and accrued current liabilities at quarter end amounted to $129 million down $10 million sequentially primarily as a result of reduced accrued CAPEX. At the end of the quarter $31 million of CAPEX was accrued for, down $5 million from the third quarter. Please turn to slide 10 as we review our capitalization. Total debt at the end of the year was $142 million, the principal components of outstanding debt include a 115.75 [ph] senior unsecured note due April 2016 and approximately $27 million in capital lease obligations. Our leverage ratio improved for 1.76 times at the end of 2013 to 1.21 times at the end of fiscal 2014. During the quarter and through today we have not borrowed on our 5 year $50 million credit agreement. Taking a look at our cash flows, cash provided by operations for the fourth quarter of 2014 was approximately $35 million. G&A was approximately $21.7 million and cash provided by operations for fiscal 2014 was $96 million with G&A amounting to $80 million. Cash flow used in investing activities amounted to approximately $33 million in fourth quarter which is primarily all CAPEX. As previously stated 2014 cash CAPEX amounted to $91 million. Net cash used by financing activities during Q4 2014 amounted $2 million and the for the year was $30 million both primarily for repayments of debt. Please turn to slide 11 as we take a look ahead. Taking a look at CAPEX we expect our 2015 cash CAPEX needs to be in the range of $100 million to $110 million. We do however have the flexibility to accelerate or decelerate our spend depending upon market conditions. We expect to generate -- continue to generate free cash flow in 2015 and our 2015 investments will be principally geared towards high end leading edge products for IC and FPD applications. Our visibility as always continues to be limited as our backlog is typically only one to two weeks. For Q1 2015 we do expect to experience some reduced orders related to typical yearend holiday seasonality. That said we are projecting revenue for the first quarter of 2015 to be in the range of $121 million to $126 million. During 2015 our tax rate will be affected by the flow of income from jurisdictions for which we may have credits and upon our limited ability to recognize cash benefits in years which we are taxable. For the first quarter of 2015 this will equate to a range of 2 million to 2.5 million in whole dollar terms and for fiscal 2015 we estimate total taxes will range from $11 million $13 million. We will continue to be impacted by the minority interest expense related to PDMC. By the first quarter of 2015 we are estimating minority interest expense to be in the range of approximately $2.5 million to $3.5 million. As a result based upon our current operating model we estimate EPS for the first quarter of 2015 to be in the range of $0.02 to $0.07 per diluted share. In summary I’ll leave you with a few key thoughts. First, we expect top and bottom-line improvement in 2015. Second, we expect our – continue to grow in 2015 and third, we are confident about our business model and our ability to grow market share to leading edge. We see continued opportunities in our customers businesses and node migrations plans and we have a strong financial position and excellent technology to capitalize on those plans. And finally we expect to continue to build on the momentum that we have established over the past few years as a leader in advanced photomask technology. Now I would like to turn the call over to the operator for Q&A